Speaker illustration

Professor Robert Rosenson

Mount Sinai Hospital, New York (United States of America)

Member of:

European Society of Cardiology

Assessment of cardiovascular disease risk using different thresholds to define high risk on the pooled cohort equations

Event: ESC Congress 2018

Topic: Cardiovascular Epidemiology

Session: Atrial fibrillation, stroke and cardiovascular risk

Thumbnail

Residual risk following myocardial infarction despite intensive medical management

Event: ESC Congress 2018

Topic: Cardiovascular Pharmacotherapy, Other

Session: Antiplatelet and anticoagulant drugs

Thumbnail

Panel discussion and Q&A - Cardiovascular risk: the dangers of blood pressure and low-density lipoprotein cholesterol.

Event: ESC CONGRESS 2017

Topic: Risk scores

Session: Cardiovascular risk: the dangers of blood pressure and low-density lipoprotein cholesterol

Thumbnail

The burden of hypertension and high cholesterol – Impact of non-compliance and failure to reach goals.

Event: ESC CONGRESS 2017

Topic: Risk scores

Session: Cardiovascular risk: the dangers of blood pressure and low-density lipoprotein cholesterol

Thumbnail

Adherence to intensive medical management in the year following hospitalization for myocardial infarction

Event: ESC CONGRESS 2017

Topic: Epidemiology, lipids

Session: Prevention - Epidemiology

Thumbnail

Statin use among HIV-infected adults by cardiovascular disease risk status

Event: ESC CONGRESS 2017

Topic: Lipids (Epidemiology and Prevention)

Session: Lipid-lowering therapy: old faces and new issues

Thumbnail

Statin use and dose by low-density lipoprotein cholesterol level in U.S. commercially insured patients with type 2 diabetes

Event: ESC CONGRESS 2016

Topic: Epidemiology, lipids

Session: Are we ever going to get to lipid goals?

Thumbnail

Increased recurrent coronary heart disease and mortality risk among intensive medically managed patients following myocardial infarction

Event: ESC CONGRESS 2016

Topic: Epidemiology, lipids

Session: The wide world of cardiovascular research and practice

Thumbnail

Trends in high-intensity statin therapy after myocardial infarction, 2011-2014

Event: ESC CONGRESS 2016

Topic: Epidemiology, lipids

Session: Cardiovascular risk in populations

Thumbnail

This platform is supported by

logo Novo Nordisk